Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108.8 USD | -2.01% | +0.10% | +1.06% |
Apr. 24 | Endeavor BioMedicines, Inc. announced that it has received $127.5 million in funding from a group of investors | CI |
Apr. 18 | T. Rowe Price says 2018 Tesla pay aligned with investor interests | RE |
Evolution of the average Target Price on T. Rowe Price Group Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering T. Rowe Price Group Inc.
TD Cowen | |
Morgan Stanley | |
JPMorgan Chase | |
UBS | |
Keefe, Bruyette & Woods | |
Citigroup | |
Deutsche Bank Securities | |
Wells Fargo Securities | |
Jefferies & Co. | |
Goldman Sachs | |
Evercore ISI | |
Credit Suisse | |
BMO Capital | |
Autonomous Research | |
Barclays |
EPS Revisions
- Stock Market
- Equities
- TROW Stock
- Consensus T. Rowe Price Group Inc.